Entrada Therapeutics Inc's market cap is currently $480.47M. The company's EPS TTM is $1.593; its P/E ratio is 8.06; Entrada Therapeutics Inc is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.67. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 129.01M	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 29.13M	$ -1.90M	$ -1.12M	$ -326.00K	$ -104.00K
Operating Income	$ -3.16M	$ -97.25M	$ -51.13M	$ -26.67M	$ -11.82M
EBITDA	$ -321.00K	$ -95.35M	$ -50.01M	$ -26.34M	$ -11.72M
Net Income	$ -6.68M	$ -87.46M	$ -50.07M	$ -26.38M	$ -4.65M
Balance Sheet
Cash & Short-Term Investments	$ 351.97M	$ 45.16M	$ 291.06M	$ 39.05M	$ 16.84M
Total Assets	$ 469.19M	$ 252.06M	$ 305.83M	$ 43.53M	$ 18.24M
Total Debt	$ 68.23M	$ 25.94M	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ 628.00K	$ -19.22M	$ -291.06M	$ -39.05M	$ -16.84M
Total Liabilities	$ 226.83M	$ 39.50M	$ 7.12M	$ 85.02M	$ 33.76M
Stockholders' Equity	$ 242.36M	$ 212.55M	$ 298.72M	$ -41.49M	$ -15.52M
Cash Flow
Free Cash Flow	$ 134.19M	$ -96.67M	$ -55.44M	$ -27.89M	$ -11.43M
Operating Cash Flow	$ 139.80M	$ -93.79M	$ -50.86M	$ -25.57M	$ -10.80M
Investing Cash Flow	$ -138.40M	$ -148.65M	$ -4.58M	$ -2.32M	$ -630.00K
Financing Cash Flow	$ 21.04M	$ 479.00K	$ 307.46M	$ 50.09M	$ 38.00K

Currency in USD

Entrada Therapeutics Inc Earnings and Revenue History

Income Statement >

Entrada Therapeutics Inc Debt to Assets

Balance Sheet >

Entrada Therapeutics Inc Cash Flow

Cash Flow >

Entrada Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing